Related Experiment Videos
Atopic eczema in children: what to do when treatment fails to work
1Department of Dermatology, Royal Alexandra Hospital for Children, Sydney, Australia.
Insights
Infants and children with atopic eczema typically improve with education, irritant avoidance, emollients, and topical steroids. Persistent symptoms warrant re-evaluation of diagnosis, coexisting conditions, and adherence to basic therapy before considering advanced treatments.
Area of Science:
- Pediatric Dermatology
- Allergy and Immunology
Background:
- Atopic eczema is a common chronic inflammatory skin condition in children.
- Standard management includes education, irritant avoidance, emollients, and topical steroids.
Purpose of the Study:
- To outline a stepwise approach for managing pediatric atopic eczema.
- To guide clinicians on when to escalate treatment for non-responsive cases.
Main Methods:
- Review of current clinical guidelines and evidence for atopic eczema management in children.
- Emphasis on diagnostic confirmation and exclusion of complicating factors.
Main Results:
- Initial treatment success is achieved through a comprehensive basic program.
- Failure to respond necessitates reassessment of diagnosis and adherence.
Conclusions:
- Correct diagnosis and adherence to basic therapy are crucial for managing pediatric atopic eczema.
- Allergy assessment and advanced therapies are reserved for severe, refractory cases.
Abstract:
Atopic eczema in infants and children usually responds to a management programme involving patient education, the avoidance of environmental irritants, the regular use of emollients and the application of topical steroids. If a child fails to respond to this management programme, the dermatologist should initially ensure that the diagnosis is correct and exclude a coexistent disease process (for example, infection or immunodeficiency) that may be hampering response to treatment. The next step is to ensure that environmental irritants have been identified and eliminated from the child's environment and that prescribed medication is being used as instructed. Allergy assessment and ancillary therapy are reserved for those infants and children with severe disease not responding to basic therapy.